US 11045482
Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors
granted A61KA61K31/435A61K31/4353
Quick answer
US patent 11045482 (Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors) held by Corcept Therapeutics Incorporated expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/435, A61K31/4353, A61K31/517, A61K31/575